Method for rendering fine oxide powder hydrophobic
    5.
    发明授权
    Method for rendering fine oxide powder hydrophobic 失效
    使氧化物细粉疏水的方法

    公开(公告)号:US4247708A

    公开(公告)日:1981-01-27

    申请号:US006162

    申请日:1979-01-24

    摘要: A method for imparting a hydrophobic property to a fine oxide powder by treating it with an organo-polysiloxane in the presence of an alkali catalyst. The method is carried out with at least 1.5% by weight of organo-polysiloxane of molecular weight not exceeding 10,000, at least 0.5% by weight of ammonia or an aliphatic amine of a boiling point lower than 100.degree. C. and at least 1.5% by weight of water are added to a dry weight of the fine oxide powder (a quantity obtained after removal of adsorption water content under reduced pressure not exceeding 5 mmHg in mercury meter at 100.degree. to 110.degree. C.). Of these additives, the ammonia or the aliphatic amine of a boiling point not exceeding 100.degree. C. is added at a temperature not exceeding 60.degree. C. Then, after an aging process for at least 15 minutes, heating is carried out to a temperature between 60.degree. and 150.degree.0 C. for a period of at least 30 minutes. All processes are carried out under normal pressure.

    摘要翻译: 通过在碱催化剂的存在下用有机聚硅氧烷处理,赋予氧化物微粉末疏水性的方法。 该方法用至少1.5重量%的分子量不超过10,000的有机聚硅氧烷,至少0.5重量%的氨或沸点低于100℃的脂族胺和至少1.5重量% 加入到氧化粉末的干重中(在100℃〜110℃下,除去吸附水含量在减压下不超过5mmHg的汞米中得到的量)。 在这些添加剂中,在不超过60℃的温度下加入沸点不超过100℃的氨或脂族胺。然后,在老化过程至少15分钟后,加热至 在60°至150°C之间至少30分钟。 所有过程都在常压下进行。

    Recombinant DNA inserted with hepatitis B virus gene, mammalian cells
transformed with cloned viral DNA, and production of hepatitis B virus
proteins
    8.
    发明授权
    Recombinant DNA inserted with hepatitis B virus gene, mammalian cells transformed with cloned viral DNA, and production of hepatitis B virus proteins 失效
    用乙型肝炎病毒基因插入的重组DNA,用克隆的病毒DNA转化的哺乳动物细胞,以及产生乙型肝炎病毒蛋白质

    公开(公告)号:US5024938A

    公开(公告)日:1991-06-18

    申请号:US883138

    申请日:1986-07-08

    CPC分类号: C07K14/005 C12N2730/10122

    摘要: A recombinant DNA comprising 3 fragments of Hepatitis B virus DNA recombined with a vector consisting essentially of 0.31 Kb replication orgin of SV40 DNA inserted into EcoRI cleavage site of Escherichia coli plasmid which is deficient in the 1.426-2.521 Kb region of inhibiting replication in mammalian cells, wherein each HBV DNA fragment is a 3.2 Kb BamHI fragment consisting of 1.9 Kb HBc gene and 1.3 Kb HBs gene, and said HBV DNA fragments are arranged in a head-to-tail tandem relationship wherein the HBc gene positions at the head and the HBs gene positions at the tail, mammalian cells transformed with the recombinant DNA, and a method of production of Hepatitis B virus proteins, i.e. HBsAg and/or HBeAg. These HBV proteins have the same immunological properties as those of the natural HBV proteins originated from human blood plasma and can be used for the preparation of HBV vaccine and diagnostic reagents.

    摘要翻译: 将包含3个乙型肝炎病毒DNA片段的重组DNA与基本上由插入到在哺乳动物细胞中抑制复制的1.426-2.521Kb区域的缺失的大肠杆菌质粒的EcoRI切割位点的SV40DNA的0.31Kb复制形式的载体重组 ,其中每个HBV DNA片段是由1.9Kb HBc基因和1.3Kb HBs基因组成的3.2Kb BamHI片段,并且所述HBV DNA片段以头对尾串联关系排列,其中HBc基因位于头部和 在尾部的HBs基因位置,用重组DNA转化的哺乳动物细胞,以及生产乙型肝炎病毒蛋白即HBsAg和/或HBeAg的方法。 这些HBV蛋白质具有与源自人血浆的天然HBV蛋白质相同的免疫学特性,可用于制备HBV疫苗和诊断试剂。